Sagility Limited has announced strong financial results for the quarter and year ended March 31, 2026. The company achieved 29.1% year-over-year revenue growth, reaching ₹71,929 million for the full fiscal year. With a strategic focus on AI-led healthcare operations, Sagility demonstrated significant margin resilience and healthy operating cash flows, positioning itself as a key technology-led partner for healthcare payers and providers globally.
Fiscal Year 2026 Financial Highlights
For the fiscal year ended March 31, 2026, Sagility reported a strong performance with revenue from operations hitting ₹71,929 million, representing a 29.1% increase compared to the previous year. The company’s Adjusted EBITDA stood at ₹18,200 million, with a margin of 25.3%. Furthermore, the Adjusted PAT reached ₹11,306 million, showcasing a robust 39.5% year-over-year growth, driven by effective cost management and operational efficiencies.
Quarterly Performance and Strategic Drivers
In the final quarter (January – March 2026), Sagility generated ₹20,243 million in revenue. The company successfully onboarded 5 new clients during the quarter, bringing the total to 17 new client wins for the fiscal year. The business expansion was supported by winning $30.7M in potential steady-state annual contract value from new business and existing client expansions.
Advancing AI and Technology Integration
Sagility continues to evolve its brand as a Tech & AI-led operations partner. The company is actively advancing AI orchestration through its proprietary SmarTec and Synchrony platforms. These tools are designed to drive smarter, end-to-end healthcare operations. Notably, the Sagility SmarTec Nurse Assist was recognized as the winner of the Augmented Intelligence award by Business Intelligence Group, highlighting the company’s commitment to innovation.
Dividend and Future Outlook
Reflecting its strong financial health and confidence in future growth, the company has declared a final dividend of ₹0.1 per share. Sagility remains focused on outcome-based healthcare solutions, leveraging its deep domain expertise to lower medical costs and improve patient outcomes through AI-driven transformation.
Source: BSE
